CN Stock MarketDetailed Quotes

300573 Shenyang Xingqi Pharmaceutical

Watchlist
  • 73.22
  • -0.40-0.54%
Market Closed Dec 27 15:00 CST
12.83BMarket Cap36.83P/E (TTM)

Shenyang Xingqi Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Operating Cash Flow
Goods sale service render cash
37.98%1.42B
34.06%838.63M
29.70%367.26M
11.46%1.4B
5.52%1.03B
3.84%625.58M
-9.63%283.17M
21.41%1.25B
31.57%976.85M
39.31%602.47M
Refunds of taxes and levies
----
----
----
28.83%13.72M
28.62%13.72M
37,959.84%6.86M
----
92.64%10.65M
8,228.91%10.67M
-86.05%18.01K
Cash received relating to other operating activities
17.45%17.51M
16.23%11.09M
199.22%11.79M
-24.48%20.46M
4.70%14.91M
-8.83%9.54M
44.25%3.94M
13.02%27.09M
189.03%14.24M
130.10%10.47M
Cash inflows from operating activities
35.90%1.44B
32.36%849.72M
32.02%379.06M
10.85%1.43B
5.76%1.06B
4.74%641.98M
-9.16%287.11M
21.59%1.29B
34.01%1B
40.22%612.95M
Goods services cash paid
16.60%126.28M
42.23%85.42M
82.55%32.03M
12.88%129.08M
8.13%108.3M
-11.97%60.06M
-57.04%17.55M
9.56%114.35M
24.13%100.15M
43.24%68.22M
Staff behalf paid
19.65%406.42M
23.60%265.76M
29.36%144.68M
26.76%459.79M
27.04%339.68M
21.69%215.02M
25.84%111.84M
39.46%362.72M
35.95%267.38M
34.88%176.69M
All taxes paid
73.24%153.66M
58.49%86.59M
-7.18%22.43M
-14.85%123.41M
-19.56%88.7M
-23.20%54.64M
-9.47%24.17M
33.26%144.93M
60.65%110.26M
69.76%71.14M
Cash paid relating to other operating activities
34.01%397.76M
8.08%225.22M
28.26%96.48M
4.85%402.15M
11.80%296.82M
28.34%208.38M
33.51%75.22M
35.88%383.56M
23.85%265.49M
18.49%162.37M
Cash outflows from operating activities
30.07%1.08B
23.21%662.98M
29.22%295.62M
10.83%1.11B
12.14%833.5M
12.47%538.1M
7.53%228.77M
33.10%1.01B
32.64%743.28M
33.80%478.42M
Net cash flows from operating activities
57.42%355.67M
79.76%186.74M
43.03%83.44M
10.94%317.57M
-12.59%225.94M
-22.78%103.88M
-43.53%58.34M
-6.74%286.26M
38.09%258.48M
69.09%134.53M
Investing cash flow
Net cash received from disposal of fix assets、 intangible assets 、other long-term asset
--70.86K
----
----
-72.33%21.24K
----
----
----
-99.60%76.76K
-99.96%5.96K
--5.96K
Cash inflows from investing activities
--70.86K
----
----
-72.33%21.24K
----
----
----
-99.67%76.76K
-99.97%5.96K
--5.96K
Cash paid to acquire fixed assets intangible assets and other long-term assets
-44.74%104.21M
-50.28%71.69M
-74.10%25.34M
-12.45%261.96M
-22.11%188.57M
-32.78%144.19M
86.41%97.84M
214.79%299.23M
390.77%242.11M
684.27%214.49M
Cash paid to acquire investments
--10M
--10M
----
----
----
----
----
----
----
----
Cash outflows from investing activities
-39.44%114.21M
-43.34%81.69M
-74.10%25.34M
-12.45%261.96M
-22.11%188.57M
-32.78%144.19M
86.41%97.84M
32.68%299.23M
390.77%242.11M
684.27%214.49M
Net cash flows from investing activities
39.47%-114.14M
43.34%-81.69M
74.10%-25.34M
12.44%-261.94M
22.11%-188.57M
32.77%-144.19M
-86.41%-97.84M
-48.09%-299.15M
-683.68%-242.11M
-684.25%-214.49M
Financing cash flow
Cash received from capital contributions
----
----
----
-8.20%25.3M
----
----
----
-95.25%27.56M
----
----
Cash from borrowing
360.00%230M
360.00%230M
--30M
250.00%70M
150.00%50M
150.00%50M
----
-80.00%20M
-80.00%20M
-80.00%20M
Cash received relating to other financing activities
-81.31%4.21M
-73.68%4.21M
----
1,452.83%23.5M
--22.52M
--15.99M
--16.05M
26.13%1.51M
----
----
Cash inflows from financing activities
222.98%234.21M
254.92%234.21M
86.94%30M
142.08%118.81M
262.58%72.52M
229.94%65.99M
-19.76%16.05M
-92.80%49.08M
-80.24%20M
-80.00%20M
Borrowing repayment
--70M
--50M
----
----
----
----
----
50.00%120M
40.90%120M
50.00%120M
Dividend interest payment
112.29%377.72M
322.83%375.89M
265.63%576.21K
120.79%178.49M
120.44%177.93M
143.80%88.9M
-66.48%157.59K
71.53%80.84M
80.05%80.71M
56.34%36.46M
Cash payments relating to other financing activities
-67.17%5.09M
-80.02%2.82M
-78.76%209.09K
267.68%24.49M
157.59%15.5M
308.95%14.11M
-53.06%984.42K
-58.71%6.66M
317.65%6.02M
39.56%3.45M
Cash outflows from financing activities
134.09%452.81M
316.18%428.71M
-31.24%785.3K
-2.18%202.98M
-6.43%193.43M
-35.58%103.01M
-99.07%1.14M
44.84%207.5M
57.29%206.73M
51.15%159.91M
Net cash flows from financing activities
-80.79%-218.6M
-425.36%-194.5M
95.99%29.21M
46.87%-84.17M
35.25%-120.91M
73.54%-37.02M
114.53%14.91M
-129.44%-158.42M
-517.57%-186.73M
-2,314.10%-139.91M
Net cash flow
Exchange rate change effecting cash and cash equivalents
-126.49%-38.7K
-85.31%7.13K
914.20%124.57K
323.17%200.02K
676.16%146.1K
2,082.18%48.52K
-284.11%-15.3K
28.31%-89.63K
74.42%-25.36K
96.13%-2.45K
Net increase in cash and cash equivalents
127.45%22.89M
-15.74%-89.45M
455.28%87.43M
83.46%-28.34M
51.05%-83.4M
64.85%-77.28M
52.44%-24.61M
-126.66%-171.4M
-235.27%-170.38M
-574.35%-219.87M
Add:Begin period cash and cash equivalents
-5.57%480.42M
-5.57%480.42M
-5.57%480.42M
-25.20%508.76M
-25.20%508.76M
-25.20%508.76M
-25.20%508.76M
1,727.46%680.16M
1,727.46%680.16M
1,727.46%680.16M
End period cash equivalent
18.33%503.31M
-9.39%390.97M
17.29%567.85M
-5.57%480.42M
-16.56%425.36M
-6.26%431.48M
-22.96%484.15M
-25.20%508.76M
212.42%509.78M
450.77%460.29M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Operating Cash Flow
Goods sale service render cash 37.98%1.42B34.06%838.63M29.70%367.26M11.46%1.4B5.52%1.03B3.84%625.58M-9.63%283.17M21.41%1.25B31.57%976.85M39.31%602.47M
Refunds of taxes and levies ------------28.83%13.72M28.62%13.72M37,959.84%6.86M----92.64%10.65M8,228.91%10.67M-86.05%18.01K
Cash received relating to other operating activities 17.45%17.51M16.23%11.09M199.22%11.79M-24.48%20.46M4.70%14.91M-8.83%9.54M44.25%3.94M13.02%27.09M189.03%14.24M130.10%10.47M
Cash inflows from operating activities 35.90%1.44B32.36%849.72M32.02%379.06M10.85%1.43B5.76%1.06B4.74%641.98M-9.16%287.11M21.59%1.29B34.01%1B40.22%612.95M
Goods services cash paid 16.60%126.28M42.23%85.42M82.55%32.03M12.88%129.08M8.13%108.3M-11.97%60.06M-57.04%17.55M9.56%114.35M24.13%100.15M43.24%68.22M
Staff behalf paid 19.65%406.42M23.60%265.76M29.36%144.68M26.76%459.79M27.04%339.68M21.69%215.02M25.84%111.84M39.46%362.72M35.95%267.38M34.88%176.69M
All taxes paid 73.24%153.66M58.49%86.59M-7.18%22.43M-14.85%123.41M-19.56%88.7M-23.20%54.64M-9.47%24.17M33.26%144.93M60.65%110.26M69.76%71.14M
Cash paid relating to other operating activities 34.01%397.76M8.08%225.22M28.26%96.48M4.85%402.15M11.80%296.82M28.34%208.38M33.51%75.22M35.88%383.56M23.85%265.49M18.49%162.37M
Cash outflows from operating activities 30.07%1.08B23.21%662.98M29.22%295.62M10.83%1.11B12.14%833.5M12.47%538.1M7.53%228.77M33.10%1.01B32.64%743.28M33.80%478.42M
Net cash flows from operating activities 57.42%355.67M79.76%186.74M43.03%83.44M10.94%317.57M-12.59%225.94M-22.78%103.88M-43.53%58.34M-6.74%286.26M38.09%258.48M69.09%134.53M
Investing cash flow
Net cash received from disposal of fix assets、 intangible assets 、other long-term asset --70.86K---------72.33%21.24K-------------99.60%76.76K-99.96%5.96K--5.96K
Cash inflows from investing activities --70.86K---------72.33%21.24K-------------99.67%76.76K-99.97%5.96K--5.96K
Cash paid to acquire fixed assets intangible assets and other long-term assets -44.74%104.21M-50.28%71.69M-74.10%25.34M-12.45%261.96M-22.11%188.57M-32.78%144.19M86.41%97.84M214.79%299.23M390.77%242.11M684.27%214.49M
Cash paid to acquire investments --10M--10M--------------------------------
Cash outflows from investing activities -39.44%114.21M-43.34%81.69M-74.10%25.34M-12.45%261.96M-22.11%188.57M-32.78%144.19M86.41%97.84M32.68%299.23M390.77%242.11M684.27%214.49M
Net cash flows from investing activities 39.47%-114.14M43.34%-81.69M74.10%-25.34M12.44%-261.94M22.11%-188.57M32.77%-144.19M-86.41%-97.84M-48.09%-299.15M-683.68%-242.11M-684.25%-214.49M
Financing cash flow
Cash received from capital contributions -------------8.20%25.3M-------------95.25%27.56M--------
Cash from borrowing 360.00%230M360.00%230M--30M250.00%70M150.00%50M150.00%50M-----80.00%20M-80.00%20M-80.00%20M
Cash received relating to other financing activities -81.31%4.21M-73.68%4.21M----1,452.83%23.5M--22.52M--15.99M--16.05M26.13%1.51M--------
Cash inflows from financing activities 222.98%234.21M254.92%234.21M86.94%30M142.08%118.81M262.58%72.52M229.94%65.99M-19.76%16.05M-92.80%49.08M-80.24%20M-80.00%20M
Borrowing repayment --70M--50M--------------------50.00%120M40.90%120M50.00%120M
Dividend interest payment 112.29%377.72M322.83%375.89M265.63%576.21K120.79%178.49M120.44%177.93M143.80%88.9M-66.48%157.59K71.53%80.84M80.05%80.71M56.34%36.46M
Cash payments relating to other financing activities -67.17%5.09M-80.02%2.82M-78.76%209.09K267.68%24.49M157.59%15.5M308.95%14.11M-53.06%984.42K-58.71%6.66M317.65%6.02M39.56%3.45M
Cash outflows from financing activities 134.09%452.81M316.18%428.71M-31.24%785.3K-2.18%202.98M-6.43%193.43M-35.58%103.01M-99.07%1.14M44.84%207.5M57.29%206.73M51.15%159.91M
Net cash flows from financing activities -80.79%-218.6M-425.36%-194.5M95.99%29.21M46.87%-84.17M35.25%-120.91M73.54%-37.02M114.53%14.91M-129.44%-158.42M-517.57%-186.73M-2,314.10%-139.91M
Net cash flow
Exchange rate change effecting cash and cash equivalents -126.49%-38.7K-85.31%7.13K914.20%124.57K323.17%200.02K676.16%146.1K2,082.18%48.52K-284.11%-15.3K28.31%-89.63K74.42%-25.36K96.13%-2.45K
Net increase in cash and cash equivalents 127.45%22.89M-15.74%-89.45M455.28%87.43M83.46%-28.34M51.05%-83.4M64.85%-77.28M52.44%-24.61M-126.66%-171.4M-235.27%-170.38M-574.35%-219.87M
Add:Begin period cash and cash equivalents -5.57%480.42M-5.57%480.42M-5.57%480.42M-25.20%508.76M-25.20%508.76M-25.20%508.76M-25.20%508.76M1,727.46%680.16M1,727.46%680.16M1,727.46%680.16M
End period cash equivalent 18.33%503.31M-9.39%390.97M17.29%567.85M-5.57%480.42M-16.56%425.36M-6.26%431.48M-22.96%484.15M-25.20%508.76M212.42%509.78M450.77%460.29M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Pharmaceutical E-commerce
Pharmaceutical E-commerce
Intraday+0.73%
Vitamins
Vitamins
Intraday+0.55%